Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Mid-range Performer

Download real time

1013.00 -5.00 (-0.49%)

138.6K NSE+BSE Volume

NSE 17 Jun, 2025 3:31 PM (IST)

12,422.3

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Alivus Life Sciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ALIVUS, BSE:543322 Alivus Life Sciences Ltd.

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

128 Votes:

Buy 75.78%

Sell 12.5%

Hold 11.72%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >